Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $371.5300 (1.31%) ($366.0700 - $372.8500) on Tue. Oct. 18, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.79% (three month average) | | RSI | 17 | | Latest Price | $371.5300(1.31%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | | Weekly Trend | REGN declines -4.2% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(62%) XLV(50%) XBI(45%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -0.895% in a week (0% probabilities).
VIXM(-9%) TLT(-8%) UUP(-7%) TIP(-3%) SHY(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.895% (StdDev 1.79%) | | Hourly BBV | 0 () | | Intraday Trend | 1.4% | | | | | |
|
| Resistance Level | $393.5 | | 5 Day Moving Average | $371.84(-0.08%) | | 10 Day Moving Average | $380.49(-2.35%) | | 20 Day Moving Average | $393.5(-5.58%) | | To recent high | -15.8% | | To recent low | 1.3% | | Market Cap | $39.393b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |